Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2013


2nd Digital Marketing for Medical Devices West

29 Apr 2013 - 01 May 2013 - San Diego, CA, USA



Bookmark and Share


Digital marketing has opened the door to opportunities never before believed possible. Based on the success of ExL’s inaugural 2012 west conference and the previous two Minneapolis conferences, we aim to further expand the industry’s leading device-specific digital marketing conference. 

Being the industry’s ONLY conference of its kind, this will allow you to dive into the many issues and emerging opportunities for digital marketing facing medical device professionals today. Participants have an opportunity to network, share ideas and explore digital marketing success stores and innovations. From mobile to social, you will learn cutting-edge trends and ideas as well as novel strategies needed for practical application.

Join 150+ experienced medical device-marketing executives in late April 2013 to share ideas and explore digital marketing success stores and innovations. From mobile to social, you will learn cutting-edge trends and ideas as well as novel strategies needed for practical application.

Key Program Sessions Include:

Leveraging global market access using digital technology

Branded content: Make it good, or don’t make it at all

Creating a comprehensive digital marketing strategy to fit the needs of your product

How to navigate social media in a regulated environment

Mobile marketing: Best practices for cracking today’s most intimate channel

Effectively combining multiple marketing strategies in a digital format

Transforming the customer experience through interactive media

Creating a interconnected multi-channel digital marketing campaign to aid sales force efforts

Advanced search marketing: Can local, social, SEM and SEO all work together?

Expanding customer website traffic through leveraging novel mobile marketing strategies

Enhancing strategy through novel cloud and customer-facing technologies

Influencing discussion: The role of patient social networks in device marketing 



Further information
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Promising Drug for Parkinson's Disease
A drug which has already been in use for decades to treat liver disease could be an effective treatment to slow down progression of Parkinson’s disease, scientists from the University of Sheffield have discovered.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!